Role of nitric oxide in the regulation of glucose kinetics in response to endotoxin in dogs
The purpose of the present in vivo study was to determine the role of nitric oxide (NO) in the regulation of glucose metabolism in response to endotoxin by blocking NO synthesis with NG-monomethyl-l-arginine (l-NMMA). In five dogs, the appearance and disappearance rates of glucose (by infusion of [6,6-2H2]glucose), plasma glucose concentration, and plasma hormone concentrations were measured on five different occasions: saline infusion, endotoxin alone ( E coli, 1.0 μg/kg iv), and endotoxin administration plus three different doses of primed, continuous infusion of l-NMMA. Endotoxin increased rate of appearance of glucose from 13.7 ± 1.6 to 23.6 ± 3.3 μmol · kg−1· min−1( P < 0.05), rate of disappearance of glucose from 13.9 ± 1.1 to 24.8 ± 3.1 μmol · kg−1· min−1( P < 0.001), plasma lactate from 0.5 ± 0.1 to 1.7 ± 0.1 mmol/l ( P < 0.01), and counterregulatory hormone concentrations. l-NMMA did not affect the rise in rate of appearance and disappearance of glucose, plasma lactate, or the counterregulatory hormone response to endoxin. Plasma glucose levels were not affected by endotoxin with or withoutl-NMMA. In conclusion, in vivo inhibition of NO synthesis by high doses of l-NMMA does not affect glucose metabolism in response to endotoxin, indicating that NO is not a major mediator of glucose metabolism during endotoxemia in dogs.